timsTOF MALDI PharmaPulse, a trapped ion mobility-enabled mass spec solution for label-free HTS in drug discovery
Watch our free live webinar to discover how the new timsTOF MPP product solution, with its dedicated MALDI PharmaPulse 2023 HTS software suite, improves data quality and accelerates high-throughput screening in drug discovery.
Key takeaways from the AACR Meeting 2022
By Victoria Rees (Drug Target Review)
Biodegradable gel boosts immune system’s attack on several cancers in mice
By Ria Kakkad (Drug Target Review)
COVID vaccine that could protect against Omicron and other variants
By Ria Kakkad (Drug Target Review)
The promise of mRNA therapeutics in producing the first regenerative treatment for SUI
By Dr Roger Dmochowski (Vanderbilt University Medical Center)
Cell line development tactics and strategies for faster Investigational New…
By Soojin Han (Samsung Biologics America)
Viewing disease through the lens of memory B cells: improving…
By Dr Purnanand Sarma (Immunome)
Neutralising SARS-CoV-2 with intranasally-delivered antibodies
By Dr Chris Takimoto (IGM Biosciences)
Emerging trends in biotherapeutic development
By Dr Andrew Bradbury (Specifica), Dr Bryan Jones (Eli Lilly…